Abiomed, Inc. Buyback
OLI recorded this information on 11/13/2012
Company:
Abiomed, Inc.
Buyback:
ABMD buyback
$Amount Authorized:
$15,000,000
Buyback Details:
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced that its Board of Directors has authorized a stock repurchase program of up to $15 million of its common stock.
ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
Open the ABMD Page at The Online Investor »
|
Open the ABMD Page at The Online Investor (in a new window) »
Free ABMD Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.40 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: ABMD Stock Forecast Based on Zacks ABR data; powered by Xignite |